Muñoz Miguel, Rosso Marisa, Carranza Andrés, Coveñas Rafael
Virgen del Rocío University Hospital, Research Laboratory on Neuropeptides (IBIS), Sevilla, Spain.
Virgen del Rocío University Hospital, Research Laboratory on Neuropeptides (IBIS), Sevilla, Spain.
Acta Histochem. 2017 Apr;119(3):337-342. doi: 10.1016/j.acthis.2017.03.003. Epub 2017 Mar 18.
Gastric cancer (GC) is an aggressive disease that remains the fourth most common type of cancer and is the second leading cause of cancer-related death worldwide. Treatment of advanced or metastatic GC has seen little progress and median overall survival in this group remains <1 year. It is urgent to investigate new mechanisms to understand GC progression. It is known that substance P (SP), after binding to the neurokinin-1 (NK-1) receptor, elicits GC proliferation; that GC cells and samples express NK-1 receptors; that NK-1 receptor antagonists, in a concentration dependent manner, inhibit the proliferation of GC cells and that these cells die by apoptosis. However, the presence of SP in GC and normal gastric cells is unknown. In order to know more on the involvement of the SP/NK-1 receptor system in GC, we studied in thirty human GC and normal gastric samples the immunolocalization of SP after using an immunohistochemical technique. SP was observed in the cytoplasm and in the nucleus of GC and normal gastric cells. The nuclear expression of SP was higher in GC cells than in normal cells. No significant difference was observed when the cytoplasmatic expression of SP in normal and GC cells was compared. The findings suggest that SP plays an important role in both nuclear function and GC.
胃癌(GC)是一种侵袭性疾病,仍然是第四大常见癌症类型,并且是全球癌症相关死亡的第二大主要原因。晚期或转移性GC的治疗进展甚微,该群体的中位总生存期仍小于1年。迫切需要研究新机制以了解GC的进展。已知P物质(SP)与神经激肽-1(NK-1)受体结合后会引发GC增殖;GC细胞和样本表达NK-1受体;NK-1受体拮抗剂以浓度依赖的方式抑制GC细胞的增殖,并且这些细胞通过凋亡死亡。然而,SP在GC细胞和正常胃细胞中的存在情况尚不清楚。为了更深入了解SP/NK-1受体系统在GC中的作用,我们使用免疫组织化学技术研究了30个人类GC和正常胃样本中SP的免疫定位。在GC细胞和正常胃细胞的细胞质和细胞核中均观察到了SP。GC细胞中SP的核表达高于正常细胞。比较正常细胞和GC细胞中SP的细胞质表达时,未观察到显著差异。这些发现表明,SP在核功能和GC中均发挥重要作用。